基层医疗机构抗高血压药物使用情况分析——基于湖北省2015～2017年数据分析

Analyzing The Status of Anti-hypertensive Drug-Using in Primary Medical Institutions Based on Data Analysis of Hubei Province from 2015 to 2017

目的:分析评价基层抗高血压药物使用情况,为高血压防控及科学管理提供数据支撑。方法:基于湖北省基层医疗卫生机构2015-2017年抗高血压药物的采购数据,利用金额排序法、ABC分析法,评价基层高血压用药现状。结果:从用药品种来看,抗高血压药物以口服制剂为主(占比86.05%);55.81%属于基本药物,84.88%属于医保药物。从用药金额来看,2015-2017年抗高血压药物采购金额呈逐年上升趋势;CCB类在高血压治疗中使用率最高,3年平均占比达50.68%;硝苯地平片、厄贝沙坦片、非洛地平片采购金额分列前3;抗高血压药物品种、金额分布基本符合ABC理论。结论:基层医疗机构高血压用药在医保报销层面可负担性较好,用药大类使用较为合理,但在用药种类选择上还需进一步优化。

Objective To analyze and evaluate the use of anti-hypertensive drugs in primary medical institutions, and provide data support for hypertension prevention and scientific management. Methods The data of purchasing anti-hypertensive medication in primary health care institutions in Hubei Province from 2015 to 2017 was evaluated by the methods of amount ranking and ABC analysis. Results The anti-hypertensive drugs were mainly oral preparations (accounting for 86. 05%). 55.81 % of them were basic drugs, and 84. 88% were medical insurance drugs. The amount of purchasing anti-hypertensive drugs kept increasing from 2015 to 2017.The CCB drugs had the highest utilization rate in the treatment of hypertension, with an average ratio of 50. 68%. The anti-hypertensive drugs as the top three amount of purchasing were Nifedipine tablets, Irbesartan tablets and Felodipine tablets. The distribution of anti-hypertensive drugs and purchasing amount was basically conformed to the ABC theory. Conclusion Hypertension medication in basic medical institutions is relatively affordable at the level of medical insurance reimbursement. And it is reasonable to use major categories of medications, but it is needed to be further optimized in the selection of medication types.